The Delhi High Court has dismissed AbbVie’s appeal regarding the refusal of their patent application for an anti-cMet antibody-drug conjugate. The court found the proposed amendments exceeded permissible scope under the Indian Patents Act.
Read more about AbbVie’s Patent Refusal Upheld over Impermissible Shift from Treatment to Product ClaimsTag: Patent Claim Amendments
Claim Amendments within the Scope of Patent Specification are Permissible, the Delhi High Court reiterates
The Delhi High Court has reaffirmed that claim amendments falling within the scope of the original patent specification are permissible under Indian law. The judgment provides clarity on Section 59(1) of the Patents Act and sets important precedent for future patent amendment cases.
Read more about Claim Amendments within the Scope of Patent Specification are Permissible, the Delhi High Court reiteratesMadras High Court’s Progressive Stance on Patent Claim Amendments and Other Aspects
In this post, we at BananaIP bring to you select Patent cases relating to Patent Claim amendments, Patent exclusions, and Patent orders. Amending polypeptide patent...
Read more about Madras High Court’s Progressive Stance on Patent Claim Amendments and Other AspectsClaim Amendments for Common Rejections during Patent Prosecution
This post examines claim amendment strategies to address common patent rejections under 35 USC 101, 102, 103, and 112. It offers practical legal insights and examples for overcoming typical issues during patent prosecution in India.
Read more about Claim Amendments for Common Rejections during Patent Prosecution